PAEDIATRIC CONSUMER HEALTH IN THE NETHERLANDS

Euromonitor International

February 2019

LIST OF CONTENTS AND TABLES

Headlines

Prospects

Healthy Value Growth Thanks To Paediatric Vitamins and Dietary Supplements

Greater Product Segmentation Will Boost the Roll-out of Paediatric Lines

Stricter EU Regulation on Paediatric Medicines in Place

Competitive Landscape

Omega Pharma Nederland Leads, Ahead of Vemedia

More Paediatric Lines in Cough, Cold and Allergy (hay Fever) Remedies

Packaging Displays Appeal To Children in Wound Care

Category Data

Table 1 Sales of Paediatric Consumer Health by Category: Value 2013-2018

Table 2 Sales of Paediatric Consumer Health by Category: % Value Growth 2013-2018

Table 3 Sales of Paediatric Vitamins and Dietary Supplements by Type: % Value 2015-2018

Table 4 NBO Company Shares of Paediatric Consumer Health: % Value 2014-2018

Table 5 LBN Brand Shares of Paediatric Consumer Health: % Value 2015-2018

Table 6 Forecast Sales of Paediatric Consumer Health by Category: Value 2018-2023

Table 7 Forecast Sales of Paediatric Consumer Health by Category: % Value Growth 2018-2023

Executive Summary

Moderate Value Growth, Largely Driven by Non-otc Categories

OTC Sales Are Not (yet) Lifted by the Brighter Macroeconomy

Pharmaceutical Multinationals Dominate, With Private Label the Main Rival

Supermarkets Gains Ground, To the Detriment of Chemists/pharmacies

Modest Value Growth Over the Forecast Period

Appendix

OTC Registration and Classification

Vitamins and Dietary Supplements Registration and Classification

Self-medication/self-care and Preventive Medicine

Switches

Summary 1 OTC: Switches

Market Indicators

Table 8 Consumer Expenditure on Health Goods and Medical Services: Value 2013-2018

Table 9 Life Expectancy at Birth 2013-2018

Market Data

Table 10 Sales of Consumer Health by Category: Value 2013-2018

Table 11 Sales of Consumer Health by Category: % Value Growth 2013-2018

Table 12 NBO Company Shares of Consumer Health: % Value 2014-2018

Table 13 LBN Brand Shares of Consumer Health: % Value 2015-2018

Table 14 Penetration of Private Label in Consumer Health by Category: % Value 2013-2018

Table 15 Distribution of Consumer Health by Format: % Value 2013-2018

Table 16 Distribution of Consumer Health by Format and Category: % Value 2018

Table 17 Forecast Sales of Consumer Health by Category: Value 2018-2023

Table 18 Forecast Sales of Consumer Health by Category: % Value Growth 2018-2023

Sources

Summary 2 Research Sources

Paediatric consumer health recorded healthy current value growth in 2018, thanks in large part to the strong performance of paediatric vitamins and dietary supplements. Since demand for vitamins and dietary supplements remained strong in general in the Netherlands, the paediatric segment was able to benefit from this development.

Euromonitor International's Paediatric Consumer Health in Netherlands report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2014-2018, allowing you to identify the sectors driving growth. Forecasts to 2023 illustrate how the market is set to change.

Product coverage: Nappy (Diaper) Rash Treatments, Paediatric Analgesics, Paediatric Cough, Cold and Allergy Remedies, Paediatric Dermatologicals, Paediatric Digestive Remedies, Paediatric Vitamins and Dietary Supplements.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Paediatric Consumer Health market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.

Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.